雜志介紹

Current Computer-aided Drug Design雜志介紹

《Current Computer-aided Drug Design》是一本以English為主的未開放獲取國際優(yōu)秀期刊，中文名稱當(dāng)前的計(jì)算機(jī)輔助藥物設(shè)計(jì)，本刊主要出版、報(bào)道醫(yī)學(xué)-CHEMISTRY, MEDICINAL領(lǐng)域的研究動(dòng)態(tài)以及在該領(lǐng)域取得的各方面的經(jīng)驗(yàn)和科研成果，介紹該領(lǐng)域有關(guān)本專業(yè)的最新進(jìn)展，探討行業(yè)發(fā)展的思路和方法，以促進(jìn)學(xué)術(shù)信息交流，提高行業(yè)發(fā)展。該刊已被國際權(quán)威數(shù)據(jù)庫SCIE收錄，為該領(lǐng)域相關(guān)學(xué)科的發(fā)展起到了良好的推動(dòng)作用，也得到了本專業(yè)人員的廣泛認(rèn)可。該刊最新影響因子為1.5，最新CiteScore 指數(shù)為3.7。

本刊近期中國學(xué)者發(fā)表的論文主要有：

• The Application of Machine Learning Techniques in Clinical Drug Therapy.

  Author: Meng HY¹, Jin WL¹, Yan CK¹, Yang H¹.

• A Novel Amino Acid Sequence-based Computational Approach to Predicting Cell-penetrating Peptides.

  Author: Tang J¹, Ning J², Liu X¹, Wu B¹, Hu R³.

• Virtual Screening Strategy Combined Bayesian Classification Model, Molecular Docking for Acetyl-CoA Carboxylases Inhibitors.

  Author: Zhou WN¹, Zhang YM¹, Qiao X¹, Pan J¹, Yin LF¹, Zhu L¹, Zhao JN¹, Lu S¹, Lu T^1,2, Chen YD¹, Liu HC¹.

• Virtual Screening for Type ⅡB Inhibitors of B-RafV600E Kinase.

  Author: Qiu KX¹, Zhang W¹, Yu F¹, Li W¹, Sun ZW¹, Zhang SQ², Chen YJ¹, Xie HD¹.

英文介紹

Current Computer-aided Drug Design雜志英文介紹

Aims & Scope

Current Computer-Aided Drug Design aims to publish all the latest developments in drug design based on computational techniques. The field of computer-aided drug design has had extensive impact in the area of drug design.

Current Computer-Aided Drug Design is an essential journal for all medicinal chemists who wish to be kept informed and up-to-date with all the latest and important developments in computer-aided methodologies and their applications in drug discovery. Each issue contains a series of timely, in-depth reviews, original research articles and letter articles written by leaders in the field, covering a range of computational techniques for drug design, screening, ADME studies, theoretical chemistry; computational chemistry; computer and molecular graphics; molecular modeling; protein engineering; drug design; expert systems; general structure-property relationships; molecular dynamics; chemical database development and usage etc., providing excellent rationales for drug development.